87 related articles for article (PubMed ID: 2365778)
1. Normal-phase high-performance liquid chromatographic procedure for the determination of diprafenone in plasma.
Austin D; Koziol T; Woolf E; Espinosa-Crouch G
J Chromatogr; 1990 Apr; 527(1):182-8. PubMed ID: 2365778
[No Abstract] [Full Text] [Related]
2. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
Zhong D; Blume H
Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective determination of diprafenone in human plasma.
Zhong D; Chen R; Fieger-Büschges H; Blume H
Pharmazie; 1997 Feb; 52(2):106-9. PubMed ID: 9122271
[TBL] [Abstract][Full Text] [Related]
4. Direct separation of the enantiomers of propafenone, diprafenone and their major metabolites by high-performance liquid chromatography on modified cellulose and amylose chiral stationary phases.
Hollenhorst T; Blaschke G
J Chromatogr; 1991 Nov; 585(2):329-32. PubMed ID: 1804845
[No Abstract] [Full Text] [Related]
5. High-performance liquid chromatographic method for the simultaneous determination of propafenone and 5-hydroxypropafenone in human serum.
Kunicki PK; Paczkowski D; Sitkiewicz D
Pol J Pharmacol Pharm; 1992; 44(2):161-71. PubMed ID: 1409116
[TBL] [Abstract][Full Text] [Related]
6. [Simultaneous determination of propafenone and its active metabolite in serum by high performance liquid chromatography].
Zhang WL; Tang YN
Yao Xue Xue Bao; 1992; 27(7):552-5. PubMed ID: 1442090
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived chiral stationary phase.
Pires de Abreu LR; Lanchote VL; Bertucci C; Cesarino EJ; Bonato PS
J Pharm Biomed Anal; 1999 Jun; 20(1-2):209-16. PubMed ID: 10704025
[TBL] [Abstract][Full Text] [Related]
8. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
Fonck K; Haenebalcke C; Hemeryck A; Belpaire F; Jordaens L; Calle P; Buylaert W
J Toxicol Clin Toxicol; 1998; 36(3):247-51. PubMed ID: 9656983
[TBL] [Abstract][Full Text] [Related]
9. Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent.
Koytchev R; Alken RG; Mayer O; Smith I; Greenwood M
Eur J Clin Pharmacol; 1996; 50(4):315-9. PubMed ID: 8803526
[TBL] [Abstract][Full Text] [Related]
10. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic analysis of propafenone in human plasma samples.
Harapat SR; Kates RE
J Chromatogr; 1982 Jul; 230(2):448-53. PubMed ID: 7107791
[No Abstract] [Full Text] [Related]
12. High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
Latini R; Sica A; Marchi S; Chen ZM; Gavinelli M; Benfenati E
J Chromatogr; 1988 Jan; 424(1):211-4. PubMed ID: 3366834
[No Abstract] [Full Text] [Related]
13. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
Trenk D; Wagner F; Sachs W; Jähnchen E
Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
[TBL] [Abstract][Full Text] [Related]
14. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
Groschner K; Lindner W; Schnedl H; Kukovetz WR
Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
[TBL] [Abstract][Full Text] [Related]
15. A liquid chromatography-electrospray tandem mass spectrometry method for the determination of antiarrhythmic drugs and their metabolites in forensic whole blood samples.
Sørensen LK
J Anal Toxicol; 2012 Mar; 36(2):116-22. PubMed ID: 22337781
[TBL] [Abstract][Full Text] [Related]
16. Propafenone poisoning--a case report with plasma propafenone concentrations.
Ovaska H; Ludman A; Spencer EP; Wood DM; Jones AL; Dargan PI
J Med Toxicol; 2010 Mar; 6(1):37-40. PubMed ID: 20373066
[TBL] [Abstract][Full Text] [Related]
17. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
Gülker H; Heuer H; Thale J; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
[TBL] [Abstract][Full Text] [Related]
18. Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
Kern R
Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):203-10. PubMed ID: 7913980
[TBL] [Abstract][Full Text] [Related]
19. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
Hinderling PH; Tendolkar A; Dee CM; Barr WH; Seiberling M; Duerr H
J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Slawson MH; Johnson-Davis KL
Methods Mol Biol; 2016; 1383():11-9. PubMed ID: 26660169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
